Lanzhou University Second Hospital
Clinical trials sponsored by Lanzhou University Second Hospital, explained in plain language.
-
New radioactive therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-phase study tested a new radioactive drug called 177Lu-CTR-FAPI in 12 people with advanced solid tumors (breast, sarcoma, thyroid) that had spread and no longer responded to standard treatments. The main goal was to check if the drug is safe and how it spreads in the b…
Phase: EARLY_PHASE1 • Sponsor: Lanzhou University Second Hospital • Aim: Disease control
Last updated May 26, 2026 10:07 UTC
-
New radioactive compound shows promise in first human tests for Hard-to-Treat cancers
Disease control CompletedThis early study tested a new radioactive drug called [177Lu]Lu-TEFAPI-06 in 5 adults with advanced solid tumors that had spread and were no longer responding to standard treatments. The main goal was to check safety and see where the drug goes in the body. Researchers also looke…
Phase: EARLY_PHASE1 • Sponsor: Lanzhou University Second Hospital • Aim: Disease control
Last updated May 26, 2026 08:19 UTC